MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.120
-0.070 (-5.88%)
At close: Oct 30, 2026, 4:00 PM EDT
1.180
+0.060 (5.36%)
After-hours: Oct 30, 2026, 7:30 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $7.38 million as of October 30, 2026. It is the 43,022nd most valuable company in the world and the 5,761st biggest in the United States. Its market cap has decreased by 69.17% in one year.
Market Cap
7.38M
Enterprise Value
-5.08M
1-Year Change
-69.17%
Global Rank
Country Rank
#5,761 United States
Category
ChartMarket Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $7.38M, a decrease of -99.99%. That is a compound annual growth rate of -75.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 7.38M | -60.19% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 8.40M |
| Tempest Therapeutics | 8.20M |
| Ensysce Biosciences | 8.19M |
| Theriva Biologics | 7.82M |
| CollPlant Biotechnologies | 7.82M |
| Soligenix | 7.75M |
| Moleculin Biotech | 7.69M |
| Vistagen Therapeutics | 7.47M |